ANDREOTTI, VIRGINIA
 Distribuzione geografica
Continente #
EU - Europa 3.263
AS - Asia 13
NA - Nord America 3
Totale 3.279
Nazione #
IT - Italia 3.263
CN - Cina 11
US - Stati Uniti d'America 3
SG - Singapore 2
Totale 3.279
Città #
Genova 1.446
Genoa 1.189
Rapallo 380
Vado Ligure 237
Bordighera 11
Beijing 4
Ashburn 3
Singapore 2
Zhengzhou 1
Totale 3.273
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 214
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer 194
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 185
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 179
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup 168
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 159
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 156
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 140
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 136
The CDKN2A/p16INK4a 5'UTR sequence and translational regulation: Impact of novel variants predisposing to melanoma 133
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 131
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding 127
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 127
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 126
Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development 125
The 5′-untranslated region of p16INK4a acts as a cellular IRES, controls mRNA translation during hypoxic and energetic stresses, and is a target of YBX1 124
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 120
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 110
Current State of Target Treatment in BRAF Mutated Melanoma 104
CDKN2A/p16INK4a 5’UTR variants in melanoma and pancreatic cancer predisposition: lost in translation, somewhere 91
Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene 84
The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape 67
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 67
An internal ribosomal entry site in the 5’-untranslated region of p16INK4a mRNA provides a novel mechanism for the regulation of its translation 65
Case Report: A BRCA2 Mutation Identified Through Next-Generation Sequencing in a Birt-Hogg-Dubè Syndrome Family 54
Molecular Assessment in Patients with Melanoma: When and Why? 54
Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma 45
null 40
A Rare Pediatric Giant Cell Tumor of the Clivus Bone, H3.3 p.Gly35Trp-mutated: Case Report and Mini-review of the Literature 38
Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome 34
Totale 3.397
Categoria #
all - tutte 12.571
article - articoli 11.498
book - libri 0
conference - conferenze 798
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 275
Totale 25.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021239 0 0 0 37 16 19 14 19 36 38 35 25
2021/2022284 3 8 19 30 17 31 12 64 27 32 7 34
2022/2023459 47 44 4 58 81 59 1 38 64 2 57 4
2023/2024252 8 26 3 35 9 40 12 32 11 16 14 46
2024/2025689 20 36 24 46 74 62 82 146 29 35 62 73
2025/2026449 158 63 140 88 0 0 0 0 0 0 0 0
Totale 3.397